Medical devices

Global ECG Sensor Patch Market to Surpass US$ 299.3 Million by 2026

Retrieved on: 
Wednesday, July 17, 2019

According to Coherent Market Insights, the global ECG sensor patch market was valued at US$ 11.7 million in 2017, and is projected to exhibit a CAGR of 43.7% over the forecast period (20182026).

Key Points: 
  • According to Coherent Market Insights, the global ECG sensor patch market was valued at US$ 11.7 million in 2017, and is projected to exhibit a CAGR of 43.7% over the forecast period (20182026).
  • Key Trends and Analysis of the Global ECG Sensor Patch Market:
    Key trends in market are rising prevalence of atrial fibrillation, technological advancement in ECG sensor patch and new product launches by the key players.
  • The global ECG sensor patch market is expected to exhibit a CAGR of 43.7% during the forecast period (20182026), owing to rising prevalence of atrial fibrillation, technological advancement in ECG sensor patch and new product launches by key players and easy detection of atrial fibrillation due to wearable ECG monitoring patch.
  • Key players operating in the global ECG sensor patch market include Medtronic Plc., Hill-Rome Holdings, Inc., iRhythm Technologies, Inc., AliveCor, Inc., Vivalnk, Inc., Cardiac Insight Inc., VitalConnect, LifeSignals, Inc., and Lief Therapeutics
    Global ECG Sensor Patch Market, By Product Type:
    Global ECG Sensor Patch Market, By Application:
    Global ECG Sensor Patch Market, By End User:
    Global ECG Sensor Patch Market, By Region:

Medical Device Contract Manufacturing Market, 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 17, 2019

The "Medical Device Contract Manufacturing Market, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Device Contract Manufacturing Market, 2019-2030" report has been added to ResearchAndMarkets.com's offering.
  • The Medical Device CMOs Market, 2019-2030 report features a comprehensive study on the current landscape of contract manufacturing service providers focused on medical devices (specifically for drug-delivery devices, diagnostic devices, and therapeutic devices).
  • The aforementioned constraints have led many of the smaller players and certain established players to outsource a significant part of their manufacturing operations to capable contract manufacturing organizations (CMOs).
  • Given the demand for medical devices, the opportunity for CMOs with expertise in medical devices is steadily rising.

Global Single Use Disposable Patient Positioning Products Market to Surpass US$ 168.6 Million By 2026

Retrieved on: 
Wednesday, July 17, 2019

According to Coherent Market Insights, the global single use disposable patient positioning products market was valued at US$ 127.7 million in 2018, and is projected to exhibit a CAGR of 3.5% during the forecast period (2018 2026).

Key Points: 
  • According to Coherent Market Insights, the global single use disposable patient positioning products market was valued at US$ 127.7 million in 2018, and is projected to exhibit a CAGR of 3.5% during the forecast period (2018 2026).
  • Key Trends and Analysis of the Single Use Disposable Patient Positioning Products Market:
    The single use disposable patient positioning products market size is expected to witness remarkable growth in the forecast period owing to increasing strategic acquisitions by key players to increase their product portfolios.
  • Moreover, the single use disposable patient positioning market is further expected to generate high revenue over the forecast period, owing to launch of Trendelenburg positioning systems in the market.
  • Global Single Use Disposable Patient Positioning Market, By Product Type:

Stimwave Appoints Regina E. Groves and Marc A. Loev, M.D., to Board of Directors and James M. Rallo as Chief Financial Officer

Retrieved on: 
Wednesday, July 17, 2019

In addition, Jims decades of financial management and public company leadership experience will help propel Stimwave into its next phase of growth and development.

Key Points: 
  • In addition, Jims decades of financial management and public company leadership experience will help propel Stimwave into its next phase of growth and development.
  • Ms. Groves brings more than three decades of deep industry experience and executive leadership to Stimwave.
  • She most recently served as CEO of REVA Medical, and prior to that held top leadership positions at Medtronic, Kaiser Permanente and McKinsey & Company.
  • This is an incredibly exciting time for Stimwave with ongoing development of its proprietary Wireless Pain Relief technology as well as awareness efforts around pain management.

Coronary Stents (Drug-eluting, Bare Metal, Bioresorbable) Markets, 2024: Bioresorbable Stents are Likely to Offer Tremendous Growth Opportunities for Vendors

Retrieved on: 
Wednesday, July 17, 2019

High CAD occurrences, technological advancements, and a steady increase in demand in emerging economies are factors responsible for growth bare metal stents.

Key Points: 
  • High CAD occurrences, technological advancements, and a steady increase in demand in emerging economies are factors responsible for growth bare metal stents.
  • Bioresorbable stents are growing at a faster pace and are likely to witness rapid growth during the forecast period.
  • With the availability of a few commercial and promising investigational devices, bioresorbable stents are likely to offer tremendous growth opportunities for vendors in coming years.
  • The permanent coronary stents segment is growing significantly and captured more than half of the market in 2018.

Know Labs Announces Significant Pre-Clinical Progress of UBAND Non-Invasive Continuous Glucose Monitor

Retrieved on: 
Wednesday, July 17, 2019

Know Labs, Inc. (OTCQB: KNWN) a creator of innovative medical diagnostic solutions, today announced significant progress in the development of its wearable UBAND non-invasive Continuous Glucose Monitor (CGM).

Key Points: 
  • Know Labs, Inc. (OTCQB: KNWN) a creator of innovative medical diagnostic solutions, today announced significant progress in the development of its wearable UBAND non-invasive Continuous Glucose Monitor (CGM).
  • Dr. James Andy Anderson, M.D., Know Labs Chief Medical Officer, stated, The UBAND CGM will be submitted for review under the FDAs De Novo pathway.
  • There is nothing else like it in the continuous glucose monitoring market, nor in the broader medical diagnostic world.
  • We initially believed our first product would be a wearable calorie counter for the consumer market, said Know Labs, Inc. CEO Phil Bosua.

GORE® ENFORM Biomaterial Earns Innovative Technology Designation from Vizient, Inc.

Retrieved on: 
Wednesday, July 17, 2019

W. L. Gore & Associates announced that GORE ENFORM Biomaterial for use in abdominal wall reconstruction procedures recently received the Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the U.S.

Key Points: 
  • W. L. Gore & Associates announced that GORE ENFORM Biomaterial for use in abdominal wall reconstruction procedures recently received the Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the U.S.
  • We are honored by Vizients Innovative technology designation, said David Lane, Business Leader, GMP, W. L. Gore & Associates, Inc. We engineered GORE ENFORM Biomaterial to work with the bodys natural healing process for a predictable result.
  • Our member council determined this technology met the criteria to be recognized with the Innovative Technology designation.
  • GORE, GORE-TEX, ENFORM and SYNECOR are trademarks of W. L. Gore & Associates
    View source version on businesswire.com: https://www.businesswire.com/news/home/20190717005142/en/

Masimo to Report Second Quarter 2019 Financial Results after Market Close on Wednesday, July 31

Retrieved on: 
Wednesday, July 17, 2019

Masimo (NASDAQ: MASI) announced today that it will release second quarter 2019 financial results for the period ended June 29, 2019, after the market closes on Wednesday, July 31, 2019.

Key Points: 
  • Masimo (NASDAQ: MASI) announced today that it will release second quarter 2019 financial results for the period ended June 29, 2019, after the market closes on Wednesday, July 31, 2019.
  • ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer.
  • After the live webcast, the call will be available on Masimo's website through August 30, 2019.
  • In addition, a telephonic replay of the call will be available through August 7, 2019.

The 2019 Home Testing Kits Market: Global Industry Analysis, Trends, Market Size and Forecasts (2017-2025) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 17, 2019

The "Home Testing Kits Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Home Testing Kits Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The report on the global home testing kits market provides qualitative and quantitative analysis for the period from 2017 to 2025.
  • The report on home testing kits market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global home testing kits market over the period of 2017 to 2025.
  • Complete coverage of all the segments in the home testing kits market to analyze the trends, developments in the global market and forecast of market size up to 2025.

Global Mobile Cardiac Telemetry Devices Market 2017-2019 & 2025 - Segmented by Technology, End-user and Region - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 17, 2019

The "Mobile Cardiac Telemetry Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Mobile Cardiac Telemetry Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The report on the global mobile cardiac telemetry devices market provides qualitative and quantitative analysis for the period from 2017 to 2025.
  • The report on mobile cardiac telemetry devices market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global mobile cardiac telemetry devices market over the period of 2017 to 2025.
  • Complete coverage of all the segments in the mobile cardiac telemetry devices market to analyze the trends, developments in the global market and forecast of market size up to 2025.